Saturday, February 21, 2026
21.7 C
Bengaluru

An Infectious Disease Specialist Speaks to Pharma on How it Needs to Change its Approach

linkedin.com/in/dr-mandar-kubal-3721352

Key Point from the Q &A with Dr. Mandar Kubal, Mumbai

Telemedicine has become a very useful tool for clinicians to manage their patients.

Given the ever changing contours of Covid19 treatment, doctors have to check daily for online resources.

It would be wonderful if pharma can provide every specialty the latest developments in treating Covid19 with pre existing conditions instead of sending their unvaccinated field force to give brand reminders.

Pharma should seek frontline worker status for Medical Reps and Field Managers as they are critical to maintain the drug supply chain.

Treat the Field Force as an asset and protect them, instead of pushing them onto the field without vaccination.

And many more insights from a clinician at the frontlines of treating Covid19 patients.

An Infectious Disease Specialist Speaks to Pharma on How it Needs to Change its Approach @YouTube

………………………………………………………………………………………………………………………….

Digital Excellence Pharma Academy (DEPA) begins a new series of conversations with doctors to Indian Pharma and insight into their challenges and how pharma needs to change its current approach to interactions with doctors

Great Opportunity for Pharma People to Listen to What Doctors have to Say https://youtu.be/wqCK574qb-g
Conversation with Dr. Deepak Krishnamurthy on Expectations of Doctors from Pharma https://youtu.be/7VVzhMlY2Uw

You can also listen to what pharma leaders from across the globe have to say about various aspects of pharma’s challenges and solutions on MedicinMan YouTube Channel – https://www.youtube.com/channel/UCEj-fkwCUJGVW0-FmipRP3A

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img